Skip to content

Clinical trials

Phase 1 Hematologic Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1 Country / region: Italy Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20161
20182
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
AbbVie1
Bellicum Pharmaceuticals1
Hoffmann-La Roche1
Kumquat Biosciences Inc.1
Kura Oncology, Inc.1
Mundipharma Research Limited1
Pfizer1
Prelude Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms10
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Mantle-Cell3
Hodgkin Disease2
Leukemia2
Leukemia, Myeloid, Acute2
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, T-Cell, Cutaneous2
Myelodysplastic Syndromes2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.